DocGo Q2 2026 Revenue Drops to $73.4M as Migrant Programs Wind Down
DocGo posted $73.4M in Q2 2026 revenue, down from $80.4M a year ago, with the entire decline tied to ending migrant-related programs.
DocGo (Nasdaq: DCGO), the company that blends mobile health clinics with medical transportation tech, just dropped its second-quarter 2026 earnings — and the headline number tells a pretty clear story. Total revenue came in at $73.4 million, sliding from $80.4 million in Q2 2025. That's roughly an $7 million dip year-over-year, which sounds concerning until you dig into *why* it happened.
Here's the key context: management says the entire revenue decline was driven by the wind-down of migrant-related programs. In other words, this wasn't a sign that DocGo's core mobile health or transportation business is shrinking — it was a specific government contract category that ran its course. That's an important distinction for investors trying to figure out whether this is a structural problem or just a chapter closing.
Read more LQR House Takes Majority Stake in AI Brokerage Fusion Five →
For everyday investors, think of it this way: DocGo had a revenue stream tied to providing healthcare services for migrant populations, likely through government contracts. When those programs wrapped up, the money stopped flowing. Strip that out, and the underlying business picture looks quite different from the raw revenue comparison.
What remains to be seen is how DocGo plans to backfill that lost revenue — whether through new government partnerships, expansion of its mobile health footprint, or growth in its medical transportation segment. The company operates at an interesting intersection of healthcare delivery and logistics technology, which gives it multiple levers to pull. Investors will be watching closely to see if management offers guidance on replacing those dollars.
Continue reading at BusinessWire
